Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB

Trends in Cell Biology

Volumn 27, Issue 6, 2017, Pages 417-429

  Catrysse, Leen ^a,b   van Loo, Geert ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN;

ADIPOSE TISSUE; CHRONIC INFLAMMATION; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; HUMAN; HYPOTHALAMUS; INFLAMMATION; INSULIN RESISTANCE; LIVER; MACROPHAGE; METABOLIC DISORDER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OVERNUTRITION; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; METABOLISM;

ANIMALS; HUMANS; INFLAMMATION; METABOLIC SYNDROME; MODELS, BIOLOGICAL; NF-KAPPA B; OBESITY; ORGAN SPECIFICITY;

EID: 85013409487     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2017.01.006     Document Type: Review

References (97)

1. Könner, A.C., Brüning, J.C., Selective insulin and leptin resistance in metabolic disorders. Cell Metab. 16 (2012), 144–152.
2. Shi, H., et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116 (2006), 3015–3025.
3. Lee, J.Y., et al. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276 (2001), 16683–16689.
4. Hommelberg, P.P.H., et al. Fatty acid-induced NF-κB activation and insulin resistance in skeletal muscle are chain length dependent. Am. J. Physiol. Endocrinol. Metab. 296 (2009), E114–E120.
5. Oh, D.Y., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142 (2010), 687–698.
6. Erridge, C., Samani, N.J., Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 1944–1949.
7. Pal, D., et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 18 (2012), 1279–1285.
8. Wong, S.W., et al. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 284 (2009), 27384–27392.
9. Könner, C.A., Brüning, J.C., Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol. Metab. 22 (2011), 16–23.
10. Tanti, J.-F., et al. Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front. Endocrinol. (Lausanne), 3, 2012, 181.
11. Bierhaus, A., Nawroth, P.P., Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 52 (2009), 2251–2263.
12. Lin, Y., et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem. 280 (2005), 4617–4626.
13. Hotamisligil, G.S., Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140 (2010), 900–917.
14. Cnop, M., et al. Endoplasmic reticulum stress, obesity and diabetes. Trends Mol. Med. 18 (2016), 59–68.
15. Eizirik, D.L., et al. Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation. Diabetologia 56 (2013), 234–241.
16. Özcan, U., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 309 (2005), 457–461.
17. Jiao, P., et al. FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKβ pathways. Obesity (Silver Spring) 19 (2011), 483–491.
18. Zhang, X., et al. Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity. Cell 135 (2008), 61–73.
19. Harte, A.L., et al. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care 35 (2012), 375–382.
20. Pussinen, P.J., et al. Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 34 (2011), 392–397.
21. Cani, P.D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (2007), 1761–1772.
22. Cani, P.D., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
23. Odegaard, J.I., Chawla, A., Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 339 (2013), 172–177.
24. Copps, K.D., White, M.F., Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55 (2012), 2565–2582.
25. Hasegawa, Y., et al. Blockade of the nuclear factor-κB pathway in the endothelium prevents insulin resistance and prolongs life spans. Circulation 125 (2012), 1122–1133.
26. Boura-Halfon, S., Zick, Y., Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 296 (2009), E581–E591.
27. Tanti, J.-F., Jager, J., Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr. Opin. Pharmacol. 9 (2009), 753–762.
28. Zhang, J., et al. S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-α signaling through IKK2. J. Biol. Chem. 283 (2008), 35375–35382.
29. Ozes, O.N., et al. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl Acad. Sci. U. S. A. 98 (2001), 4640–4645.
30. Lee, D.-F., et al. IKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance. Int. J. Mol. Med. 22 (2008), 633–638.
31. Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29 (2011), 415–445.
32. Shoelson, S.E., et al. Inflammation and insulin resistance. J. Clin. Invest. 116 (2006), 1793–1801.
33. Zabolotny, J.M., et al. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J. Biol. Chem. 283 (2008), 14230–14241.
34. Holland, W.L., et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121 (2011), 1858–1870.
35. Samuel, V.T., Shulman, G.I., Mechanisms for insulin resistance: common threads and missing links. Cell 148 (2012), 852–871.
36. Vandanmagsar, B., et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17 (2011), 179–188.
37. Yuan, M., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IkKβ. Science 293 (2001), 1673–1677.
38. Chiang, S.-H., et al. The protein kinase IKKε regulates energy balance in obese mice. Cell 138 (2009), 961–975.
39. Tang, T., et al. Uncoupling of inflammation and insulin resistance by NF-κB in transgenic mice through elevated energy expenditure. J. Biol. Chem. 285 (2010), 4637–4644.
40. Gao, Z., et al. Inactivation of NF-κB p50 leads to insulin sensitization in liver through post-translational inhibition of p70S6K. J. Biol. Chem. 284 (2009), 18368–18376.
41. Minegishi, Y., et al. Deletion of nuclear factor-κB p50 upregulates fatty acid utilization and contributes to an anti-obesity and high-endurance phenotype in mice. Am. J. Physiol. Endocrinol. Metab. 309 (2015), E523–E533.
42. Rosen, E.D., Spiegelman, B.M., What we talk about when we talk about fat. Cell 156 (2014), 20–44.
43. Ota, T., Chemokine systems link obesity to insulin resistance. Diabetes Metab. J. 37 (2013), 165–172.
44. Cildir, G., et al. Chronic adipose tissue inflammation: all immune cells on the stage. Trends Mol. Med. 19 (2013), 487–500.
45. Cinti, S., et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46 (2005), 2347–2355.
46. Jiao, P., et al. Constitutive activation of IKKβ in adipose tissue prevents diet-induced obesity in mice. Endocrinology 153 (2012), 154–165.
47. Haiyan, X.U., et al. Exclusive action of transmembrane TNFα in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology 143 (2002), 1502–1511.
48. Blüher, M., et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 3 (2002), 25–38.
49. Lee, K.Y., et al. Lessons on conditional gene targeting in mouse adipose tissue. Diabetes 62 (2013), 864–874.
50. Li, S., et al. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl Acad. Sci. U. S. A. 107 (2010), 3441–3446.
51. Cohen, J.C., et al. Human fatty liver disease: old questions and new insights. Science 332 (2011), 1519–1523.
52. Devisscher, L., et al. The role of macrophages in obesity-driven chronic liver disease. J. Leukoc. Biol. 99 (2016), 693–698.
53. Cai, D., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat. Med. 11 (2005), 183–190.
54. Sunami, Y., et al. Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammation. Hepatology 56 (2012), 1117–1128.
55. Lu, H., et al. Moderate activation of IKK2–NF-κB in unstressed adult mouse liver induces cytoprotective genes and lipogenesis without apparent signs of inflammation or fibrosis. BMC Gastroenterol., 15, 2015, 94.
56. Arkan, M.C., et al. IKK-β links inflammation to obesity-induced insulin resistance. Nat. Med. 11 (2005), 191–198.
57. Ke, B., et al. Inactivation of NF-κB p65 (RelA) in liver improves insulin sensitivity and inhibits cAMP/PKA pathway. Diabetes 64 (2015), 3355–3362.
58. Gruben, N., et al. Cholesterol-induced hepatic inflammation does not underlie the predisposition to insulin resistance in dyslipidemic female LDL receptor knockout mice. J. Diabetes Res., 2015, 2015, 956854.
59. Funke, A., et al. Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice. Atherosclerosis 232 (2014), 390–396.
60. Aparicio-Vergara, M., Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model. Hepatology 57 (2013), 566–576.
61. Wunderlich, F.T., et al. Hepatic NF-κB essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis. Proc. Natl Acad. Sci. U. S. A. 105 (2008), 1297–1302.
62. Luedde, T., et al. Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11 (2007), 119–132.
63. Kondylis, V., et al. NEMO prevents steatohepatitis and hepatocellular carcinoma by inhibiting RIPK1 kinase activity-mediated hepatocyte apoptosis. Cancer Cell 28 (2015), 582–598.
64. Luedde, T., et al. IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver. Proc. Natl Acad. Sci. U. S. A. 105 (2008), 9733–9738.
65. Koppe, C., et al. IκB kinase α/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator receptor-interacting protein kinase 1. Hepatology 64 (2016), 1217–1231.
66. Park, E.J., et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140 (2010), 197–208.
67. Sheng, L., et al. NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat. Med. 18 (2012), 943–949.
68. Eckardt, K., et al. Myokines in insulin resistance and type 2 diabetes. Diabetologia 57 (2014), 1087–1099.
69. Röhl, M., et al. Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance. J. Clin. Invest. 113 (2004), 474–481.
70. Cai, D., et al. IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell 119 (2004), 285–298.
71. Kälin, S., et al. Hypothalamic innate immune reaction in obesity. Nat. Rev. Endocrinol. 11 (2015), 339–351.
72. De Souza, C.T., et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146 (2005), 4192–4199.
73. Purkayastha, S., Cai, D., Neuroinflammatory basis of metabolic syndrome. Mol. Metab. 2 (2013), 356–363.
74. Vogt, M.C., Brüning, J.C., CNS insulin signaling in the control of energy homeostasis and glucose metabolism – from embryo to old age. Trends Endocrinol. Metab. 24 (2013), 76–84.
75. Benzler, J., et al. Central inhibition of IKKβ/NF-κB signaling attenuates high-fat diet-induced obesity and glucose intolerance. Diabetes 64 (2015), 2015–2027.
76. Tsaousidou, E., et al. Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance. Cell Rep. 9 (2014), 1495–1506.
77. Weissmann, L., et al. IKKε is key to induction of insulin resistance in the hypothalamus, and its inhibition reverses obesity. Diabetes 63 (2014), 3334–3345.
78. Reilly, S.M., et al. An inhibitor of the protein kinases TBK1/IKKε improves obesity-related metabolic dysfunctions. Nat. Med. 19 (2013), 313–321.
79. Imai, Y., et al. Islet inflammation: a unifying target for diabetes treatment?. Trends Endocrinol. Metab. 24 (2013), 351–360.
80. Ehses, J.A., et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56 (2007), 2356–2370.
81. Giannoukakis, N., et al. Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an IκB repressor. J. Biol. Chem. 275 (2000), 36509–36513.
82. Eldor, R., et al. Conditional and specific NF-κB blockade protects pancreatic beta cells from diabetogenic agents. Proc. Natl Acad. Sci. U. S. A. 103 (2006), 5072–5077.
83. Cardozo, A.K., et al. A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J. Biol. Chem. 276 (2001), 48879–48886.
84. Ortis, F., et al. Induction of nuclear factor-κB and its downstream genes by TNF-α and IL-1β has a pro-apoptotic role in pancreatic beta cells. Diabetologia 51 (2008), 1213–1225.
85. Heimberg, H., et al. Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents beta-cell apoptosis. Diabetes 50 (2001), 2219–2224.
86. Baker, M.S., et al. Expression of a dominant negative inhibitor of NF-κB protects MIN6 beta-cells from cytokine-induced apoptosis. J. Surg. Res. 97 (2001), 117–122.
87. Malle, E.K., et al. Nuclear factor κB-inducing kinase activation as a mechanism of pancreatic β cell failure in obesity. J. Exp. Med. 212 (2015), 1239–1254.
88. Kolka, C.M., Bergman, R.N., The endothelium in diabetes: its role in insulin access and diabetic complications. Rev. Endocr. Metab. Disord. 14 (2013), 13–19.
89. Odegaard, J.I., et al. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab. 7 (2008), 496–507.
90. Osborn, O., Olefsky, J.M., The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18 (2012), 363–374.
91. Kraakman, M.J., et al. Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function?. Front. Immunol., 5, 2014, 470.
92. Greten, F.R., et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004), 285–296.
93. Tencerova, M., et al. Activated Kupffer cells inhibit insulin sensitivity in obese mice. FASEB J. 29 (2015), 2959–2969.
94. Donath, M.Y., et al. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab. 17 (2013), 860–872.
95. Hayden, M.S., Ghosh, S., NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26 (2012), 203–234.
96. Sun, S.-C., Non-canonical NF-κB signaling pathway. Cell Res. 21 (2011), 71–85.
97. Grootjans, J., et al. The unfolded protein response in immunity and inflammation. Nat. Rev. Immunol. 16 (2016), 469–484.